Virtual reality-induced dopamine reward hypothesis for opioid addiction
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
While the opioid epidemic continues to plague the globe, scant research exists into the opportunities of virtual reality (VR) therapy for opioid addiction treatment. Furthermore, few to no studies have explored the potential of VR as a dopamine replacement solution for the dopamine deficiency caused by opioid withdrawal. Therefore, this theoretical research article sought to address this research gap by proposing a hypothesis framework involving VR exposure immediately following administration of the tapered opioid medication to help the patient associate the opioid-induced reward experience with the simulation. This method would then compare dopamine levels during VR exposure to corresponding levels 20 minutes following administration of the medication to assess whether the reward memory from the VR experience has the capacity to essentially compensate for dopamine deficiency during opioid withdrawal.
Downloads
Citations
CRediT authorship contribution
Sarah Katz, conceptualization, methodology, data curation, writing - original draft, writing - review & editing.
Data Availability Statement
No new data was synthesized for the writing of this article.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.